BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34333276)

  • 1. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
    Tao Y; Chen H; Liu D; Dai X
    Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
    Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
    Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
    Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
    Bledsoe JR; Redd RA; Hasserjian RP; Soumerai JD; Nishino HT; Boyer DF; Ferry JA; Zukerberg LR; Harris NL; Abramson JS; Sohani AR
    Am J Hematol; 2016 Oct; 91(10):E436-41. PubMed ID: 27419920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of children and adolescents with gray zone lymphoma: A case series.
    Perwein T; Lackner H; Ebetsberger-Dachs G; Beham-Schmid C; Zach K; Tamesberger M; Simonitsch-Klupp I; Lüftinger R; Dworzak M; Mann G; Benesch M; Attarbaschi A;
    Pediatr Blood Cancer; 2020 May; 67(5):e28206. PubMed ID: 32037692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
    Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
    Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
    Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
    Xavier AC; Armeson KE; Hill EG; Costa LJ
    Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?
    Pervez S; Khawaja RD
    Pathol Res Pract; 2010 Jun; 206(6):365-7. PubMed ID: 20185248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
    Dunleavy K; Grant C; Eberle FC; Pittaluga S; Jaffe ES; Wilson WH
    Curr Hematol Malig Rep; 2012 Sep; 7(3):241-7. PubMed ID: 22833351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
    Gerber NK; Atoria CL; Elkin EB; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
    Chiappella A; Casadei B; Chiusolo P; Di Rocco A; Ljevar S; Magni M; Angelillo P; Barbui AM; Cutini I; Dodero A; Bonifazi F; Tisi MC; Bramanti S; Musso M; Farina M; Martino M; Novo M; Grillo G; Patriarca F; Zacchi G; Krampera M; Pennisi M; Galli E; Martelli M; Ferreri AJM; Ferrari S; Saccardi R; Bermema A; Guidetti A; Miceli R; Zinzani PL; Corradini P
    Leukemia; 2024 May; 38(5):1107-1114. PubMed ID: 38459167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
    Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
    Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
    Hsi ED; Sup SJ; Alemany C; Tso E; Skacel M; Elson P; Alonso MA; Pohlman B
    Am J Clin Pathol; 2006 May; 125(5):776-82. PubMed ID: 16707382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
    Xiao M; Lin J; Xiao T; Lin Y; Ye Y
    Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Utility of CD200 Immunohistochemistry in Distinguishing EBV-Positive Large B-Cell Lymphoma From Classic Hodgkin Lymphoma.
    Batuello C; Mason EF
    Am J Clin Pathol; 2023 Sep; 160(3):284-291. PubMed ID: 37227967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
    Aussedat G; Traverse-Glehen A; Stamatoullas A; Molina T; Safar V; Laurent C; Michot JM; Hirsch P; Nicolas-Virelizier E; Lamure S; Regny C; Picquenot JM; Ledoux-Pilon A; Tas P; Chassagne-Clément C; Manson G; Lemal R; Fontaine J; Le Cann M; Salles G; Ghesquières H; Copie-Bergman C; Sarkozy C
    Br J Haematol; 2020 Apr; 189(2):244-256. PubMed ID: 32030731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.